SavedAdd your journal

Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2011 / Cilt: 45 - Sayı: 4

Atopic dermatitis

Atopik dermatit

Sibel ALPER
Bengü TÜRK GERÇEKER
Pages
168–173
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, etiopathogenesis, clinical characteristics and current therapeutic approaches of atopic dermatitis is reviewed under highlights of recently published guidelines and the literature. (Turk derm 2011; 45: 168-73)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atopic dermatitis is one of the important public health problems of the industrialized communities, and the prevalence of the disease has been increasing in our developing country.
📊
Key Findings & Data:Atopic dermatitis is one of the important public health problems of the industrialized communities, and the prevalence of the disease has been increasing in our developing country.
💡
Conclusion & Impact:In this paper, etiopathogenesis, clinical characteristics and current therapeutic approaches of atopic dermatitis is reviewed under highlights of recently published guidelines and the literature. (Turk derm 2011; 45: 168-73)
🔬Design:Review & Systematic Survey
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Atopic dermatitis is one of the important public health problems of the industrialized communities, and the prevalence of the disease has been increasing in our developing country. In this paper, etiopathogenesis, clinical characteristics and current therapeutic approaches of atopic dermatitis is reviewed under highlights of recently published guidelines and the literature. (Turk derm 2011; 45: 168-73)

Özet

Atopik dermatit sanayileşmiş toplumlarda önemli bir sağlık sorunu olarak karşımıza çıkarken, gelişmekte olan ülkemizde ise sıklığı giderek artış göstermektedir. Bu derlemede, etyopatogenezi, klinik bulguları ve güncel tedavi yaklaşımları son kılavuzlar ve literatür eşliğinde gözden geçirilerek aktarılmaktadır. (Türk derm 2011; 45: 168-73)

🔖

Cite This Article

ALPER, S., GERÇEKER, B. T. (2022). Atopic dermatitis. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 45 - Sayı: 4, 168–173. https://ajindex.com/articles/621984

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kang K, Polster AM, Nedorost ST, Stevens SR, Cooper KD: Atopic dermatitis. Dermatology. Ed. Bolognia JL, Jorizzo JL, Rapini RP. Spain, Mosby 2008; 181-95
  2. Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, et al: European Task Force on Atopic Dermatitis/EADV Eczema Task Force. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol 2010; 24:317-28
  3. Bieber T: Atopic dermatitis. Ann Dermatol 2010; 22:125-37
  4. Kalyoncu AF, Cöplü L, Selçuk ZT, Emri AS, Kolaçan B, Kocabaş A, et al: Survey of the allergic status of patients with bronchial asthma in Turkey: a multicenter study. Allergy 1995; 50:451-5
  5. Civelek E, Sahiner UM, Yüksel H, Boz AB, Orhan F, Uner A: Prevalence, burden, and risk factors of atopic eczema in schoolchildren aged10-11 years: a national multicenter study. J Investig Allergol Clin Immunol 2011; 21:270-7
  6. Slattery MJ, Essex MJ, Paletz EM, Vanness ER, Infante M, Rogers GM, Gern JE: Depression, anxiety, and dermatologic quality of life in adolescents with atopic dermatitis. J Allergy Clin Immunol 2011; 128:668-71
  7. Morar N, Cookson WO, Harper JI, Moffatt MF: Filaggrin mutations in childrenwith severe atopic dermatitis. J Invest Dermatol 2007; 127:1667-72
  8. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38:441-6
  9. O'Regan GM, Irvine AD: The role of filaggrin in the atopic diathesis. Clin Exp Allergy 2010; 40:965-72
  10. Honda T, Miyachi Y, Kabashima K: Regulatory T cells in cutaneous immune responses. J Dermatol Sci 2011; 63:75-82
  11. Hayashida S, Uchi H, Moroi Y, Furue M: Decrease in circulating Th17 cellscorrelates with increased levels of CCL17, IgE and eosinophils in atopic dermatitis. J Dermatol Sci. 2011; 6:180-6
  12. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3:673-680
  13. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006; 203:269-273
  14. Toyoda M, Nakamura M, Makino T, Hino T, Kagoura M, Morohashi M: Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147:71-79
  15. Jungersted JM, Scheer H, Mempel M, Baurecht H, C